APAC CRISPR Gene Detection and Diagnostics Market - Industry Trends and Forecast to 2029

Description

List of Tables

The Asia-Pacific CRISPR gene detection and diagnostic market is projected to register a CAGR of 21.6% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2019, the base year of calculation is 2021 and the forecast period is 2022 to 2029

Market Segmentation:

Asia-Pacific CRISPR Gene Detection and Diagnostic Market, By Class (Class 1- Multiple Effector Proteins and Class 2 -Single CrRNA-Binding Protein), Products & Services (Products and Services), Application (Biomedical Diagnostics, Genome Engineering, Drug Discovery, Agricultural Applications and Others), Workflow (Sample Preparation, Pre-Amplification, CrRNA, Cas Enzymes and Sensing), End User (Hospitals, Diagnostic Centers, Biotechnology Companies, Academic and Research Institutes and Others), Distribution Channel (Direct Tender, Retail Sales) Country (Japan, China, India, Australia, Singapore, South Korea, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of the North America CRISPR gene detection and diagnostic market are:

The rise in prevalence and incidence of chronic diseases

Rise in investment in research and development

Market Players:

Some of the major players operating in the market are:

GenScript

Takara Bio Inc.

OriGene Technologies, Inc.

Agilent Technologies, Inc.

Synthego

Merck KGaA

Integrated DNA Technologies, Inc. (A subsidiary of Danaher)

Thermo Fisher Scientific Inc.

1 INTRODUCTION 24

1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 24
1.3 OVERVIEW OF ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET 25
1.4 CURRENCY AND PRICING 27
1.5 LIMITATIONS 27
1.6 MARKETS COVERED 28

2 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: SEGMENTATION 31

2.1 MARKETS COVERED 31
2.2 GEOGRAPHICAL SCOPE 32
2.3 YEARS CONSIDERED FOR THE STUDY 33
2.4 DBMR TRIPOD DATA VALIDATION MODEL 34
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 37
2.6 MULTIVARIATE MODELLING 38
2.7 CLASS SEGMENT LIFELINE CURVE 38
2.8 DBMR MARKET POSITION GRID 39
2.9 VENDOR SHARE ANALYSIS 41
2.10 MARKET END USER COVERAGE GRID 42
2.11 SECONDARY SOURCES 43

3 EXECUTIVE SUMMARY 44

4 PREMIUM INSIGHTS 48

4.1 PESTEL 49
4.2 PORTER'S FIVE FORCES MODEL 50

5 INTELLECTUAL PROPERTY LANDSCAPE (PATENT LANDSCAPE) 51

6 EPIDEMIOLOGY 54

7 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: REGULATORY SCENARIO 55

8 PIPELINE ANALYSIS FOR ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, OF CRISPR DIAGNOSTICS 57

9 MARKET OVERVIEW 58

9.1 DRIVERS 60
- 9.1.1 RISE IN PREVALENCE AND INCIDENCE OF CHRONIC DISEASES 60
- 9.1.2 RISE IN INVESTMENT IN RESEARCH AND DEVELOPMENT 62
- 9.1.3 AVAILABILITY OF FUNDING FOR CRISPR GENE DIAGNOSTICS 63
- 9.1.4 RISE IN GMP-CERTIFICATION APPROVALS FOR CRISPR GENE DIAGNOSTIC 63
- 9.1.5 RISE IN CLINICAL TRIALS FOR CRISPR BASED DIAGNOSTICS 63
9.2 RESTRAINTS 64
- 9.2.1 RISE IN COST OF CRISPR BASED DIAGNOSTICS 64
- 9.2.2 RISKS FACED WHILE USING CRISPR DIAGNOSIS 64
- 9.2.3 ETHICAL CONCERNS RELATED TO CRISPR GENE DETECTION AND DIAGNOSTIC RESEARCH 65
- 9.2.4 AVAILABILITY OF ALTERNATIVES 65
9.3 OPPORTUNITIES 65
- 9.3.1 STRATEGIC INITIATIVE BY MARKET PLAYERS 65
- 9.3.2 RISE IN HEALTHCARE EXPENDITURE 66
- 9.3.3 EMERGENCE OF TECHNOLOGICAL ADVANCEMENTS IN CRISPR BASED DIAGNOSTICS 66
9.4 CHALLENGES 67
- 9.4.1 LACK OF SKILLED PROFESSIONALS REQUIRED FOR CRISPR DIAGNOSTICS 67
- 9.4.2 STRINGENT REGULATIONS 67

10 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY CLASS 69

10.1 OVERVIEW 70
10.2 CLASS-2 SINGLE CRRNA-BINDING PROTEIN 73
- 10.2.1 BIOMEDICAL DIAGNOSTICS 74
- 10.2.2 AGRICULTURAL APPLICATIONS 74
- 10.2.3 GENOME ENGINEERING 74
- 10.2.4 DRUG DISCOVERY 74
- 10.2.5 OTHERS 74
10.3 CLASS-1 MULTIPLE EFFECTOR PROTEINS 75

11 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES 76

11.1 OVERVIEW 77
11.2 PRODUCTS 80
- 11.2.1 ASSAY KITS 81
  - 11.2.1.1 SGRNA KIT 81
  - 11.2.1.2 GENOMIC DETECTION KIT 81
  - 11.2.1.3 OTHERS 82
- 11.2.2 PROTEINS 82
  - 11.2.2.1 CAS9 82
  - 11.2.2.2 CPF1 82
  - 11.2.2.3 OTHERS 82
- 11.2.3 PLASMID AND VECTOR 83
- 11.2.4 LIBRARY 83
- 11.2.5 CONTROL KITS 83
- 11.2.6 DELIVERY SYSTEM PRODUCTS 83
- 11.2.7 DESIGN TOOLS 83
- 11.2.8 GENOMIC RNA 83
- 11.2.9 HDR BLOCKERS 83
  - 11.2.9.1 AZIDOTHYMIDINE 84
  - 11.2.9.2 TRIFLUOROTHYMIDINE 84
  - 11.2.9.3 OTHERS 84
  - 11.2.9.4 OTHERS 84
11.3 SERVICES 84
- 11.3.1 G-RNA DESIGN 85
- 11.3.2 CELL LINE ENGINEERING 85
- 11.3.3 MICROBIAL GENE EDITING 85
- 11.3.4 DNA SYNTHESIS 86
- 11.3.5 OTHERS 86

12 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION 87

12.1 OVERVIEW 88
12.2 BIOMEDICAL DIAGNOSTICS 91
- 12.2.1 CANCER 92
- 12.2.2 BLOOD DISORDERS 92
- 12.2.3 HEREDITARY DISORDERS 92
- 12.2.4 MUSCULAR DYSTROPHY 92
- 12.2.5 AIDS 92
- 12.2.6 NEURODEGENERATIVE CONDITION 92
- 12.2.7 OTHERS 93
12.3 AGRICULTURAL APPLICATIONS 93
12.4 GENOME ENGINEERING 93
- 12.4.1 CELL LINE ENGINEERING 94
- 12.4.2 HUMAN STEM CELLS 94
12.5 DRUG DISCOVERY 95
12.6 OTHERS 96

13 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW 97

13.1 OVERVIEW 98
13.2 CRRNA 101
13.3 CAS ENZYME 101
13.4 PRE-AMPLIFICATION 102
- 13.4.1 PCR 103
- 13.4.2 LAMP 103
- 13.4.3 RPA 103
13.5 SAMPLE PREPARATION 103
13.6 SENSING 104
- 13.6.1 FLUORESCENT PROBES 105
- 13.6.2 COLORIMETRIC 105

14 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY END USER 106

14.1 OVERVIEW 107
14.2 BIOTECHNOLOGY COMPANIES 110
14.3 ACADEMIC AND RESEARCH INSTITUTES 111
14.4 DIAGNOSTIC CENTERS 112
14.5 HOSPITALS 113
14.6 OTHERS 114

15 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL 115

15.1 OVERVIEW 116
15.2 DIRECT TENDER 120
15.3 RETAIL SALES 121

16 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION 122

16.1 ASIA-PACIFIC 123
- 16.1.1 CHINA 132
- 16.1.2 JAPAN 137
- 16.1.3 INDIA 142
- 16.1.4 SOUTH KOREA 147
- 16.1.5 AUSTRALIA 152
- 16.1.6 SINGAPORE 157
- 16.1.7 THAILAND 162
- 16.1.8 PHILIPPINES 167
- 16.1.9 MALAYSIA 172
- 16.1.10 INDONESIA 177
- 16.1.11 REST OF ASIA-PACIFIC 182

17 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: COMPANY LANDSCAPE 183

17.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 183

18 SWOT ANALYSIS 184

19 COMPANY PROFILE 185

19.1 THERMO FISHER SCIENTIFIC INC. 185
- 19.1.1 COMPANY SNAPSHOT 185
- 19.1.2 REVENUE ANALYSIS 185
- 19.1.3 COMPANY SHARE ANALYSIS 186
- 19.1.4 PRODUCT PORTFOLIO 186
- 19.1.5 RECENT DEVELOPMENTS 187
19.2 MERCK KGA 188
- 19.2.1 COMPANY SNAPSHOT 188
- 19.2.2 REVENUE ANALYSIS 188
- 19.2.3 COMPANY SHARE ANALYSIS 189
- 19.2.4 PRODUCT PORTFOLIO 189
- 19.2.5 RECENT DEVELOPMENTS 190

19.3 AGILENT TECHNILOGIES, INC 192
- 19.3.1 COMPANY SNAPSHOT 192
- 19.3.2 REVENUE ANALYSIS 192
- 19.3.3 COMPANY SHARE ANALYSIS 193
- 19.3.4 PRODUCT PORTFOLIO 193
- 19.3.5 RECENT DEVELOPMENT 194
19.4 INTEGRATED DNA TECHNOLOGIES, INC. (A SUBSIDIARY OF DANAHER) 195
- 19.4.1 COMPANY SNAPSHOT 195
- 19.4.2 REVENUE ANALYSIS 195
- 19.4.3 COMPANY SHARE ANALYSIS 196
- 19.4.4 PRODUCT PORTFOLIO 196
- 19.4.5 RECENT DEVELOPMENTS 197
19.5 GENSCRIPT 198
- 19.5.1 COMPANY SNAPSHOT 198
- 19.5.2 REVENUE ANALYSIS 198
- 19.5.3 COMPANY SHARE ANALYSIS 199
- 19.5.4 PRODUCT PORTFOLIO 199
- 19.5.5 RECENT DEVELOPMENT 200
19.6 10 X GENOMICS 201
- 19.6.1 COMPANY SNAPSHOT 201
- 19.6.2 REVENUE ANALYSIS 201
- 19.6.3 PRODUCT PORTFOLIO 202
- 19.6.4 RECENT DEVELOPMENTS 202
19.7 APPLIED STEM CELL 203
- 19.7.1 COMPANY SNAPSHOT 203
- 19.7.2 PRODUCT PORTFOLIO 203
- 19.7.3 RECENT DEVELOPMENT 203
19.8 ADDGENE 204
- 19.8.1 COMPANY SNAPSHOT 204
- 19.8.2 PRODUCT PORTFOLIO 204
- 19.8.3 RECENT DEVELOPMENT 204
19.9 BIOVISION INC. 205
- 19.9.1 COMPANY SNAPSHOT 205
- 19.9.2 PRODUCT PORTFOLIO 205
- 19.9.3 RECENT DEVELOPMENT 206
19.10 CELLECTA, INC 207
- 19.10.1 COMPANY SNAPSHOT 207
- 19.10.2 PRODUCT PORTFOLIO 207
- 19.10.3 RECENT DEVELOPMENTS 208

19.11 CAS TAG BIOSCIENCES 209
- 19.11.1 COMPANY SNAPSHOT 209
- 19.11.2 PRODUCT PORTFOLIO 209
- 19.11.3 RECENT DEVELOPMENT 209
19.12 GENECOPOEIA, INC. 210
- 19.12.1 COMPANY SNAPSHOT 210
- 19.12.2 PRODUCT PORTFOLIO 210
- 19.12.3 RECENT DEVELOPMENT 210
19.13 HORIZON DISCOVERY LTD 211
- 19.13.1 COMPANY SNAPSHOT 211
- 19.13.2 PRODUCT PORTFOLIO 211
- 19.13.3 RECENT DEVELOPMENTS 212
19.14 HERA BIOLABS 213
- 19.14.1 COMPANY SNAPSHOT 213
- 19.14.2 PRODUCT PORTFOLIO 213
- 19.14.3 RECENT DEVELOPMENT 214
19.15 NEW ENGLAND BIOLABS 215
- 19.15.1 COMPANY SNAPSHOT 215
- 19.15.2 PRODUCT PORTFOLIO 215
- 19.15.3 RECENT DEVELOPMENTS 216
19.16 ORIGENE TECHNOLOGIES, INC. 217
- 19.16.1 COMPANY SNAPSHOT 217
- 19.16.2 PRODUCT PORTFOLIO 217
- 19.16.3 RECENT DEVELOPMENT 218
19.17 SYNTHEGO 219
- 19.17.1 COMPANY SNAPSHOT 219
- 19.17.2 PRODUCT PORTFOLIO 219
- 19.17.3 RECENT DEVELOPMENTS 219
19.18 TAKARA BIO INC. 221
- 19.18.1 COMPANY SNAPSHOT 221
- 19.18.2 REVENUE ANALYSIS 221
- 19.18.3 PRODUCT PORTFOLIO 222
- 19.18.4 RECENT DEVELOPMENT 222
19.19 TOOLGEN, INC. 223
- 19.19.1 COMPANY SNAPSHOT 223
- 19.19.2 PRODUCT PORTFOLIO 223
- 19.19.3 RECENT DEVELOPMENT 223

20 QUESTIONNAIRE 224

21 RELATED REPORTS 227

LIST OF TABLES

TABLE 1 PIPELINE ANALYSIS FOR ASIA PACIFIC CRISPR GENE THERAPEUTICS 57
TABLE 2 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY CLASS, 2020-2029 (USD MILLION) 72
TABLE 3 ASIA PACIFIC CLASS-2 SINGLE CRRNA-BINDING PROTEIN IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 73
TABLE 4 ASIA PACIFIC CLASS-2 SINGLE CRRNA-BINDING PROTEIN IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 73
TABLE 5 ASIA PACIFIC CLASS-1 MULTIPLE EFFECTOR PROTEINS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 75
TABLE 6 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION) 79
TABLE 7 ASIA PACIFIC PRODUCTS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 80
TABLE 8 ASIA PACIFIC PRODUCTS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 81
TABLE 9 ASIA PACIFIC ASSAY KITS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 81
TABLE 10 ASIA PACIFIC PROTEINS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 82
TABLE 11 ASIA PACIFIC HDR BLOCKERS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 83
TABLE 12 ASIA PACIFIC SERVICES IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 85
TABLE 13 ASIA PACIFIC SERVICES IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 85
TABLE 14 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 90
TABLE 15 ASIA PACIFIC BIOMEDICAL DIAGNOSTICS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 91
TABLE 16 ASIA PACIFIC BIOMEDICAL DIAGNOSTICS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 92
TABLE 17 ASIA PACIFIC AGRICULTURAL APPLICATIONS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 93
TABLE 18 ASIA PACIFIC GENOME ENGINEERING IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 94
TABLE 19 ASIA PACIFIC GENOME ENGINEERING IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 94
TABLE 20 ASIA PACIFIC DRUG DISCOVERYIN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 95
TABLE 21 ASIA PACIFIC OTHERS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 96
TABLE 22 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 100
TABLE 23 ASIA PACIFIC CRRNA IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 101
TABLE 24 ASIA PACIFIC CAS ENZYME IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 102
TABLE 25 ASIA PACIFIC PRE-AMPLIFICATION IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 102
TABLE 26 ASIA PACIFIC PRE-AMPLIFICATION IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 103
TABLE 27 ASIA PACIFIC SAMPLE PREPARATION IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 104
TABLE 28 ASIA PACIFIC SENSING IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 104
TABLE 29 ASIA PACIFIC SENSING IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 105
TABLE 30 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY END USER, 2020-2029 (USD MILLION) 109
TABLE 31 ASIA PACIFIC BIOTECHNOLOGY COMPANIES IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 110
TABLE 32 ASIA PACIFIC ACADEMIC AND RESEARCH INSTITUTES IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 111
TABLE 33 ASIA PACIFIC DIAGNOSTIC CENTERS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 112
TABLE 34 ASIA PACIFIC HOSPITALS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 113
TABLE 35 ASIA PACIFIC OTHERS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 114
TABLE 36 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 119
TABLE 37 ASIA PACIFIC DIRECT TENDER IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 120
TABLE 38 ASIA PACIFIC RETAIL SALES IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY REGION, 2020-2029 (USD MILLION) 121
TABLE 39 ASIA-PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 127
TABLE 40 ASIA-PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY CLASS, 2020-2029 (USD MILLION) 127
TABLE 41 ASIA-PACIFIC CLASS-2 SINGLE CRRNA-BINDING PROTEIN IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 127
TABLE 42 ASIA-PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION) 128
TABLE 43 ASIA-PACIFIC PRODUCTS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 128
TABLE 44 ASIA-PACIFIC ASSAY KITS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 128
TABLE 45 ASIA-PACIFIC HDR BLOCKERS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 128
TABLE 46 ASIA-PACIFIC PROTEINS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 129
TABLE 47 ASIA-PACIFIC SERVICES IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 129
TABLE 48 ASIA-PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 129
TABLE 49 ASIA-PACIFIC GENOME ENGINEERING IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 129
TABLE 50 ASIA-PACIFIC BIOMEDICAL DIAGNOSTICS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 130
TABLE 51 ASIA-PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 130
TABLE 52 ASIA-PACIFIC PRE-AMPLIFICATION IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 130
TABLE 53 ASIA-PACIFIC SENSING IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 130
TABLE 54 ASIA-PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY END USER, 2020-2029 (USD MILLION) 131
TABLE 55 ASIA-PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 131
TABLE 56 CHINA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY CLASS, 2020-2029 (USD MILLION) 132
TABLE 57 CHINA CLASS-2 SINGLE CRRNA-BINDING PROTEIN IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 132
TABLE 58 CHINA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION) 132
TABLE 59 CHINA PRODUCTS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 133
TABLE 60 CHINA ASSAY KITS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 133
TABLE 61 CHINA HDR BLOCKERS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 133
TABLE 62 CHINA PROTEINS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 133
TABLE 63 CHINA SERVICES IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 134
TABLE 64 CHINA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 134
TABLE 65 CHINA GENOME ENGINEERING IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 134
TABLE 66 CHINA BIOMEDICAL DIAGNOSTICS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 134
TABLE 67 CHINA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 135
TABLE 68 CHINA PRE-AMPLIFICATION IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 135
TABLE 69 CHINA SENSING IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 135
TABLE 70 CHINA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY END USER, 2020-2029 (USD MILLION) 135
TABLE 71 CHINA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 136
TABLE 72 JAPAN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY CLASS, 2020-2029 (USD MILLION) 137
TABLE 73 JAPAN CLASS-2 SINGLE CRRNA-BINDING PROTEIN IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 137
TABLE 74 JAPAN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION) 137
TABLE 75 JAPAN PRODUCTS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 138
TABLE 76 JAPAN ASSAY KITS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 138
TABLE 77 JAPAN HDR BLOCKERS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 138
TABLE 78 JAPAN PROTEINS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 138
TABLE 79 JAPAN SERVICES IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 139
TABLE 80 JAPAN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 139
TABLE 81 JAPAN GENOME ENGINEERING IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 139
TABLE 82 JAPAN BIOMEDICAL DIAGNOSTICS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 139
TABLE 83 JAPAN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 140
TABLE 84 JAPAN PRE-AMPLIFICATION IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 140
TABLE 85 JAPAN SENSING IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 140
TABLE 86 JAPAN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY END USER, 2020-2029 (USD MILLION) 140
TABLE 87 JAPAN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 141
TABLE 88 INDIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY CLASS, 2020-2029 (USD MILLION) 142
TABLE 89 INDIA CLASS-2 SINGLE CRRNA-BINDING PROTEIN IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 142
TABLE 90 INDIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION) 142
TABLE 91 INDIA PRODUCTS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 143
TABLE 92 INDIA ASSAY KITS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 143
TABLE 93 INDIA HDR BLOCKERS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 143
TABLE 94 INDIA PROTEINS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 143
TABLE 95 INDIA SERVICES IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 144
TABLE 96 INDIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 144
TABLE 97 INDIA GENOME ENGINEERING IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 144
TABLE 98 INDIA BIOMEDICAL DIAGNOSTICS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 144
TABLE 99 INDIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 145
TABLE 100 INDIA PRE-AMPLIFICATION IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 145
TABLE 101 INDIA SENSING IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 145
TABLE 102 INDIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY END USER, 2020-2029 (USD MILLION) 145
TABLE 103 INDIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 146
TABLE 104 SOUTH KOREA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY CLASS, 2020-2029 (USD MILLION) 147
TABLE 105 SOUTH KOREA CLASS-2 SINGLE CRRNA-BINDING PROTEIN IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 147
TABLE 106 SOUTH KOREA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION) 147
TABLE 107 SOUTH KOREA PRODUCTS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 148
TABLE 108 SOUTH KOREA ASSAY KITS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 148
TABLE 109 SOUTH KOREA HDR BLOCKERS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 148
TABLE 110 SOUTH KOREA PROTEINS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 148
TABLE 111 SOUTH KOREA SERVICES IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 149
TABLE 112 SOUTH KOREA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 149
TABLE 113 SOUTH KOREA GENOME ENGINEERING IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 149
TABLE 114 SOUTH KOREA BIOMEDICAL DIAGNOSTICS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 149
TABLE 115 SOUTH KOREA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 150
TABLE 116 SOUTH KOREA PRE-AMPLIFICATION IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 150
TABLE 117 SOUTH KOREA SENSING IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 150
TABLE 118 SOUTH KOREA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY END USER, 2020-2029 (USD MILLION) 150
TABLE 119 SOUTH KOREA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 151
TABLE 120 AUSTRALIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY CLASS, 2020-2029 (USD MILLION) 152
TABLE 121 AUSTRALIA CLASS-2 SINGLE CRRNA-BINDING PROTEIN IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 152
TABLE 122 AUSTRALIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION) 152
TABLE 123 AUSTRALIA PRODUCTS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 153
TABLE 124 AUSTRALIA ASSAY KITS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 153
TABLE 125 AUSTRALIA HDR BLOCKERS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 153
TABLE 126 AUSTRALIA PROTEINS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 153
TABLE 127 AUSTRALIA SERVICES IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 154
TABLE 128 AUSTRALIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 154
TABLE 129 AUSTRALIA GENOME ENGINEERING IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 154
TABLE 130 AUSTRALIA BIOMEDICAL DIAGNOSTICS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 154
TABLE 131 AUSTRALIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 155
TABLE 132 AUSTRALIA PRE-AMPLIFICATION IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 155
TABLE 133 AUSTRALIA SENSING IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 155
TABLE 134 AUSTRALIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY END USER, 2020-2029 (USD MILLION) 155
TABLE 135 AUSTRALIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 156
TABLE 136 SINGAPORE CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY CLASS, 2020-2029 (USD MILLION) 157
TABLE 137 SINGAPORE CLASS-2 SINGLE CRRNA-BINDING PROTEIN IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 157
TABLE 138 SINGAPORE CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION) 157
TABLE 139 SINGAPORE PRODUCTS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 158
TABLE 140 SINGAPORE ASSAY KITS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 158
TABLE 141 SINGAPORE HDR BLOCKERS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 158
TABLE 142 SINGAPORE PROTEINS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 158
TABLE 143 SINGAPORE SERVICES IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 159
TABLE 144 SINGAPORE CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 159
TABLE 145 SINGAPORE GENOME ENGINEERING IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 159
TABLE 146 SINGAPORE BIOMEDICAL DIAGNOSTICS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 159
TABLE 147 SINGAPORE CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 160
TABLE 148 SINGAPORE PRE-AMPLIFICATION IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 160
TABLE 149 SINGAPORE SENSING IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 160
TABLE 150 SINGAPORE CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY END USER, 2020-2029 (USD MILLION) 160
TABLE 151 SINGAPORE CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 161
TABLE 152 THAILAND CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY CLASS, 2020-2029 (USD MILLION) 162
TABLE 153 THAILAND CLASS-2 SINGLE CRRNA-BINDING PROTEIN IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 162
TABLE 154 THAILAND CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION) 162
TABLE 155 THAILAND PRODUCTS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 163
TABLE 156 THAILAND ASSAY KITS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 163
TABLE 157 THAILAND HDR BLOCKERS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 163
TABLE 158 THAILAND PROTEINS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 163
TABLE 159 THAILAND SERVICES IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 164
TABLE 160 THAILAND CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 164
TABLE 161 THAILAND GENOME ENGINEERING IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 164
TABLE 162 THAILAND BIOMEDICAL DIAGNOSTICS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 164
TABLE 163 THAILAND CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 165
TABLE 164 THAILAND PRE-AMPLIFICATION IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 165
TABLE 165 THAILAND SENSING IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 165
TABLE 166 THAILAND CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY END USER, 2020-2029 (USD MILLION) 165
TABLE 167 THAILAND CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 166
TABLE 168 PHILIPPINES CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY CLASS, 2020-2029 (USD MILLION) 167
TABLE 169 PHILIPPINES CLASS-2 SINGLE CRRNA-BINDING PROTEIN IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 167
TABLE 170 PHILIPPINES CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION) 167
TABLE 171 PHILIPPINES PRODUCTS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 168
TABLE 172 PHILIPPINES ASSAY KITS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 168
TABLE 173 PHILIPPINES HDR BLOCKERS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 168
TABLE 174 PHILIPPINES PROTEINS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 168
TABLE 175 PHILIPPINES SERVICES IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 169
TABLE 176 PHILIPPINES CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 169
TABLE 177 PHILIPPINES GENOME ENGINEERING IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 169
TABLE 178 PHILIPPINES BIOMEDICAL DIAGNOSTICS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 169
TABLE 179 PHILIPPINES CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 170
TABLE 180 PHILIPPINES PRE-AMPLIFICATION IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 170
TABLE 181 PHILIPPINES SENSING IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 170
TABLE 182 PHILIPPINES CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY END USER, 2020-2029 (USD MILLION) 170
TABLE 183 PHILIPPINES CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 171
TABLE 184 MALAYSIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY CLASS, 2020-2029 (USD MILLION) 172
TABLE 185 MALAYSIA CLASS-2 SINGLE CRRNA-BINDING PROTEIN IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 172
TABLE 186 MALAYSIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION) 172
TABLE 187 MALAYSIA PRODUCTS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 173
TABLE 188 MALAYSIA ASSAY KITS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 173
TABLE 189 MALAYSIA HDR BLOCKERS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 173
TABLE 190 MALAYSIA PROTEINS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 173
TABLE 191 MALAYSIA SERVICES IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 174
TABLE 192 MALAYSIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 174
TABLE 193 MALAYSIA GENOME ENGINEERING IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 174
TABLE 194 MALAYSIA BIOMEDICAL DIAGNOSTICS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 174
TABLE 195 MALAYSIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 175
TABLE 196 MALAYSIA PRE-AMPLIFICATION IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 175
TABLE 197 MALAYSIA SENSING IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 175
TABLE 198 MALAYSIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY END USER, 2020-2029 (USD MILLION) 175
TABLE 199 MALAYSIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 176
TABLE 200 INDONESIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY CLASS, 2020-2029 (USD MILLION) 177
TABLE 201 INDONESIA CLASS-2 SINGLE CRRNA-BINDING PROTEIN IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 177
TABLE 202 INDONESIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION) 177
TABLE 203 INDONESIA PRODUCTS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 178
TABLE 204 INDONESIA ASSAY KITS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 178
TABLE 205 INDONESIA HDR BLOCKERS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 178
TABLE 206 INDONESIA PROTEINS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 178
TABLE 207 INDONESIA SERVICES IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY TYPE, 2020-2029 (USD MILLION) 179
TABLE 208 INDONESIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 179
TABLE 209 INDONESIA GENOME ENGINEERING IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 179
TABLE 210 INDONESIA BIOMEDICAL DIAGNOSTICS IN CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 179
TABLE 211 INDONESIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 180
TABLE 212 INDONESIA PRE-AMPLIFICATION IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 180
TABLE 213 INDONESIA SENSING IN GENE DETECTION AND DIAGNOSTIC MARKET, BY WORKFLOW, 2020-2029 (USD MILLION) 180
TABLE 214 INDONESIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY END USER, 2020-2029 (USD MILLION) 180
TABLE 215 INDONESIA CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 181
TABLE 216 REST OF ASIA-PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET, BY CLASS, 2020-2029 (USD MILLION) 182

LIST OF FIGURES

FIGURE 1 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: SEGMENTATION 31
FIGURE 2 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: DATA TRIANGULATION 34
FIGURE 3 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: DROC ANALYSIS 35
FIGURE 4 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS 36
FIGURE 5 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: COMPANY RESEARCH ANALYSIS 36
FIGURE 6 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: INTERVIEW DEMOGRAPHICS 37
FIGURE 7 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: DBMR POSITION GRID 39
FIGURE 8 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: VENDOR SHARE ANALYSIS 41
FIGURE 9 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: END USER COVERAGE GRID 42
FIGURE 10 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: SEGMENTATION 46
FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029 47
FIGURE 12 INCREASED INCIDENCE OF CHRONIC DISEASES, RISE IN TECHNOLOGICAL ADVANCEMENTS IN CRISPR DIAGNOSTICS, AND GOVERNMENT FUNDING FOR THE DEVELOPMENT OF CRISPR DETECTION KITS ARE EXPECTED TO DRIVE THE ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET FROM 2022 TO 2029 48
FIGURE 13 CLASS SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET FROM 2022 & 2029 48
FIGURE 14 ASIA PACIFIC CRISPR GENE PATENT SCENARIO, BY APPLICATION 51
FIGURE 15 CRISPR PATENT LANDSCAPE AND NUMBER OF APPLICATIONS OF NEW PATENT FAMILIES FILED WORLDWIDE, 2001 TO 2019 52
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET 59
FIGURE 17 INCIDENCE OF VARIOUS TYPES OF CANCER IN 2020 61
FIGURE 18 PREVALENCE OF HUNTINGTON'S DISEASE IN 2019 62
FIGURE 19 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY CLASS, 2021 70
FIGURE 20 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY CLASS, 2022-2029 (USD MILLION) 71
FIGURE 21 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY CLASS, CAGR (2022-2029) 71
FIGURE 22 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY CLASS, LIFELINE CURVE 72
FIGURE 23 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, 2021 77
FIGURE 24 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, 2022-2029 (USD MILLION) 78
FIGURE 25 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, CAGR (2022-2029) 78
FIGURE 26 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, LIFELINE CURVE 79
FIGURE 27 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY APPLICATION, 2021 88
FIGURE 28 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY APPLICATION, 2022-2029 (USD MILLION) 89
FIGURE 29 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY APPLICATION, CAGR (2022-2029) 89
FIGURE 30 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY APPLICATION, LIFELINE CURVE 90
FIGURE 31 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY WORKFLOW, 2021 98
FIGURE 32 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY WORKFLOW, 2022-2029 (USD MILLION) 99
FIGURE 33 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY WORKFLOW, CAGR (2022-2029) 99
FIGURE 34 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY WORKFLOW, LIFELINE CURVE 100
FIGURE 35 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY END USER, 2021 107
FIGURE 36 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY END USER, 2022-2029 (USD MILLION) 108
FIGURE 37 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY END USER, CAGR (2022-2029) 108
FIGURE 38 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY END USER, LIFELINE CURVE 109
FIGURE 39 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, 2021 117
FIGURE 40 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION) 118
FIGURE 41 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029) 118
FIGURE 42 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 119
FIGURE 43 ASIA-PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: SNAPSHOT (2021) 124
FIGURE 44 ASIA-PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY COUNTRY (2021) 125
FIGURE 45 ASIA-PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY COUNTRY (2022 & 2029) 125
FIGURE 46 ASIA-PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY COUNTRY (2021 & 2029) 126
FIGURE 47 ASIA-PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: BY CLASS (2022 & 2029) 126
FIGURE 48 ASIA PACIFIC CRISPR GENE DETECTION AND DIAGNOSTIC MARKET: COMPANY SHARE 2021 (%) 183